TY - JOUR
T1 - Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation
AU - Pascolini, Giulia
AU - Gaudioso, Federica
AU - Passarelli, Chiara
AU - Novelli, Antonio
AU - Di Giosaffatte, Niccolò
AU - Majore, Silvia
AU - Grammatico, Paola
N1 - © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/12
Y1 - 2021/12
N2 - X-linked intellectual disability can be diagnosed in about 10-12% of intellectually disabled males. In the past, mutations affecting the PAK3 gene (p21 protein-activated kinase 3, MIM#300142) have been associated with a non-syndromic form of X-linked intellectual disability, which has to date been identified in a limited number of families.Since this neurodevelopmental disorder mostly afflicts males, descriptions of symptomatic female carriers are quite rare.We describe a female patient with neurodevelopmental delay and a novel PAK3 variant. Interestingly, she manifests craniofacial anomalies, including microcephaly, representing the second reported microcephalic female but the first for whom a detailed clinical description is available. She also displays other uncommon clinical findings, which we illustrate.Moreover, a comprehensive clinical and molecular review of all to date published patients has been made. This study contributes to further delineate the PAK3-related phenotype, which can be considered a non-syndromic X-linked intellectual disability, with seemingly recurrent craniofacial abnormalities.
AB - X-linked intellectual disability can be diagnosed in about 10-12% of intellectually disabled males. In the past, mutations affecting the PAK3 gene (p21 protein-activated kinase 3, MIM#300142) have been associated with a non-syndromic form of X-linked intellectual disability, which has to date been identified in a limited number of families.Since this neurodevelopmental disorder mostly afflicts males, descriptions of symptomatic female carriers are quite rare.We describe a female patient with neurodevelopmental delay and a novel PAK3 variant. Interestingly, she manifests craniofacial anomalies, including microcephaly, representing the second reported microcephalic female but the first for whom a detailed clinical description is available. She also displays other uncommon clinical findings, which we illustrate.Moreover, a comprehensive clinical and molecular review of all to date published patients has been made. This study contributes to further delineate the PAK3-related phenotype, which can be considered a non-syndromic X-linked intellectual disability, with seemingly recurrent craniofacial abnormalities.
KW - Child, Preschool
KW - Developmental Disabilities/genetics
KW - Female
KW - Humans
KW - Intellectual Disability/genetics
KW - Microcephaly/genetics
KW - Mutation
KW - Phenotype
KW - p21-Activated Kinases/genetics
U2 - 10.1007/s12031-021-01868-w
DO - 10.1007/s12031-021-01868-w
M3 - Article
C2 - 34227036
SN - 0895-8696
VL - 71
SP - 2474
EP - 2481
JO - Journal of Molecular Neuroscience
JF - Journal of Molecular Neuroscience
IS - 12
ER -